| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
59,455 |
56,183 |
$15.44M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
25,287 |
23,865 |
$11.00M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
60,111 |
57,765 |
$10.83M |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
51,386 |
12,401 |
$7.64M |
| 80053 |
Comprehensive metabolic panel |
24,146 |
20,856 |
$6.32M |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
2,516 |
1,402 |
$6.05M |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
1,234 |
1,131 |
$5.70M |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
2,936 |
2,663 |
$5.54M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
65,962 |
64,979 |
$5.05M |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
34,183 |
32,130 |
$4.16M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,776 |
9,346 |
$3.26M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,029 |
4,658 |
$3.12M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,249 |
2,183 |
$2.56M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
12,029 |
11,229 |
$2.48M |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
18,698 |
18,309 |
$2.34M |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
11,450 |
3,893 |
$2.20M |
| 80050 |
General health panel |
2,995 |
2,810 |
$1.96M |
| 76825 |
|
657 |
606 |
$1.86M |
| 42830 |
|
404 |
382 |
$1.59M |
| 76770 |
|
2,593 |
2,519 |
$1.58M |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
609 |
583 |
$1.48M |
| 80061 |
Lipid panel |
5,335 |
5,010 |
$1.48M |
| 72082 |
|
2,515 |
2,441 |
$1.36M |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
24,467 |
23,552 |
$1.17M |
| 84443 |
Thyroid stimulating hormone (TSH) |
5,961 |
5,660 |
$1.13M |
| 93320 |
|
963 |
876 |
$1.09M |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
10,192 |
9,600 |
$1.07M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
31,464 |
30,899 |
$1.03M |
| 84439 |
|
9,573 |
9,060 |
$979K |
| 81001 |
|
24,729 |
22,966 |
$963K |
| 93304 |
|
941 |
790 |
$843K |
| 94375 |
|
2,045 |
1,971 |
$819K |
| S8301 |
Infection control supplies, not otherwise specified |
196,547 |
138,099 |
$704K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
16,218 |
16,032 |
$698K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
5,447 |
5,267 |
$667K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
13,309 |
11,842 |
$637K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
6,971 |
6,511 |
$634K |
| 85027 |
|
11,138 |
9,232 |
$591K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
313 |
292 |
$567K |
| 67311 |
|
178 |
96 |
$497K |
| 93325 |
|
3,086 |
2,674 |
$480K |
| 88300 |
|
1,378 |
1,316 |
$475K |
| 85007 |
|
11,090 |
9,193 |
$475K |
| 93321 |
|
969 |
846 |
$468K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,307 |
735 |
$464K |
| 87631 |
|
7,044 |
6,329 |
$460K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
5,012 |
4,744 |
$442K |
| Q3014 |
Telehealth originating site facility fee |
2,509 |
2,415 |
$424K |
| 71046 |
Radiologic examination, chest; 2 views |
3,582 |
3,460 |
$398K |
| 84100 |
|
3,471 |
2,844 |
$379K |
| 82570 |
|
2,710 |
2,163 |
$371K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
9,054 |
8,786 |
$319K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
13,743 |
13,543 |
$313K |
| 73100 |
|
1,426 |
1,207 |
$298K |
| 94060 |
|
520 |
487 |
$288K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
63 |
61 |
$286K |
| 83970 |
|
1,666 |
1,509 |
$265K |
| 73521 |
|
787 |
741 |
$233K |
| 76827 |
|
63 |
57 |
$233K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
49 |
47 |
$233K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
878 |
836 |
$229K |
| 87807 |
|
3,026 |
3,014 |
$228K |
| 86140 |
|
7,018 |
6,565 |
$222K |
| 96130 |
|
613 |
450 |
$217K |
| 84156 |
|
1,462 |
1,175 |
$215K |
| 74018 |
|
3,112 |
2,981 |
$210K |
| 77073 |
|
513 |
504 |
$190K |
| 83735 |
|
2,856 |
2,352 |
$168K |
| 73070 |
|
904 |
752 |
$166K |
| 83516 |
|
1,047 |
978 |
$165K |
| 85652 |
|
2,154 |
2,039 |
$159K |
| 95782 |
|
52 |
52 |
$151K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,700 |
1,669 |
$149K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,177 |
1,148 |
$147K |
| 73090 |
|
711 |
553 |
$145K |
| 82728 |
|
923 |
843 |
$143K |
| 73620 |
|
722 |
539 |
$140K |
| 73560 |
|
638 |
560 |
$128K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
607 |
599 |
$125K |
| 83525 |
|
1,081 |
993 |
$124K |
| 70486 |
|
49 |
49 |
$123K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
79 |
78 |
$114K |
| 83540 |
|
861 |
786 |
$113K |
| 83550 |
|
858 |
783 |
$113K |
| 81002 |
|
2,160 |
2,116 |
$108K |
| 81025 |
|
2,689 |
2,593 |
$107K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
26 |
26 |
$98K |
| 76000 |
|
230 |
224 |
$90K |
| 84550 |
|
703 |
631 |
$89K |
| 86161 |
|
704 |
673 |
$89K |
| 86160 |
|
713 |
681 |
$88K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
4,064 |
4,044 |
$86K |
| 99001 |
|
3,682 |
3,557 |
$85K |
| 82610 |
|
1,403 |
1,197 |
$76K |
| C1889 |
Implantable/insertable device, not otherwise classified |
917 |
876 |
$75K |
| 85046 |
|
1,479 |
1,321 |
$70K |
| 84436 |
|
481 |
447 |
$70K |
| 92567 |
|
939 |
912 |
$67K |
| 82784 |
|
980 |
931 |
$67K |
| 96112 |
|
149 |
139 |
$63K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
146 |
93 |
$59K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,406 |
2,070 |
$56K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
12 |
12 |
$55K |
| 86800 |
|
469 |
444 |
$54K |
| 86376 |
|
498 |
471 |
$50K |
| 73120 |
|
219 |
190 |
$46K |
| 73140 |
|
231 |
196 |
$45K |
| 86235 |
|
80 |
79 |
$45K |
| 83002 |
|
348 |
321 |
$44K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
8,723 |
7,982 |
$43K |
| 83001 |
|
315 |
293 |
$38K |
| 95811 |
|
14 |
14 |
$36K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
146 |
93 |
$36K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
140 |
131 |
$35K |
| 80197 |
|
259 |
197 |
$35K |
| 87040 |
|
382 |
352 |
$34K |
| 72141 |
|
15 |
14 |
$32K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
148 |
131 |
$29K |
| 92582 |
|
86 |
81 |
$26K |
| 17106 |
|
24 |
24 |
$26K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,656 |
5,145 |
$26K |
| 77072 |
|
212 |
205 |
$22K |
| 92587 |
|
183 |
180 |
$20K |
| 92579 |
|
98 |
97 |
$20K |
| 82657 |
|
27 |
24 |
$18K |
| 93017 |
|
13 |
13 |
$17K |
| 95816 |
|
31 |
31 |
$17K |
| 73502 |
|
93 |
85 |
$16K |
| 82043 |
|
91 |
80 |
$16K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
129 |
114 |
$16K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
37 |
13 |
$15K |
| 83690 |
|
436 |
404 |
$15K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,602 |
2,339 |
$15K |
| 69210 |
|
91 |
57 |
$14K |
| 99170 |
|
48 |
44 |
$14K |
| 82977 |
|
89 |
69 |
$14K |
| J3490 |
Unclassified drugs |
1,824 |
1,426 |
$14K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
103 |
96 |
$14K |
| 86003 |
|
59 |
26 |
$14K |
| 96131 |
|
64 |
49 |
$13K |
| J2704 |
Injection, propofol, 10 mg |
3,158 |
2,807 |
$13K |
| 84403 |
|
41 |
39 |
$12K |
| 80047 |
|
48 |
45 |
$12K |
| 72170 |
|
53 |
53 |
$12K |
| 93308 |
|
13 |
13 |
$11K |
| 80177 |
|
77 |
74 |
$10K |
| 87077 |
|
89 |
76 |
$9K |
| 73630 |
|
43 |
37 |
$9K |
| 84146 |
|
68 |
61 |
$8K |
| 92526 |
|
119 |
39 |
$8K |
| 57452 |
|
30 |
25 |
$8K |
| 73610 |
|
50 |
50 |
$8K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
745 |
727 |
$8K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
61 |
26 |
$7K |
| 92552 |
|
48 |
46 |
$7K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
480 |
390 |
$7K |
| 82465 |
|
59 |
59 |
$7K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
524 |
495 |
$7K |
| 73590 |
|
32 |
25 |
$6K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
110 |
106 |
$6K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
721 |
652 |
$6K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
3,489 |
3,457 |
$5K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
851 |
773 |
$5K |
| 80074 |
|
14 |
13 |
$5K |
| 94664 |
|
5,518 |
5,350 |
$5K |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
834 |
796 |
$5K |
| 83615 |
|
40 |
25 |
$5K |
| 87070 |
|
57 |
50 |
$5K |
| 86706 |
|
83 |
81 |
$4K |
| 96409 |
|
19 |
14 |
$4K |
| 82785 |
|
62 |
51 |
$4K |
| 84300 |
|
29 |
26 |
$4K |
| 86225 |
|
48 |
47 |
$4K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
87 |
87 |
$4K |
| 97162 |
|
12 |
12 |
$4K |
| L3908 |
Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf |
163 |
161 |
$3K |
| 82550 |
|
27 |
25 |
$3K |
| 84480 |
|
36 |
36 |
$3K |
| 95012 |
|
99 |
80 |
$3K |
| 84145 |
|
24 |
24 |
$3K |
| 83655 |
|
25 |
25 |
$3K |
| 82945 |
|
21 |
15 |
$3K |
| 89051 |
|
22 |
15 |
$3K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
467 |
464 |
$3K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
505 |
394 |
$3K |
| 70360 |
|
12 |
12 |
$2K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
353 |
310 |
$2K |
| 88106 |
|
20 |
13 |
$2K |
| 87186 |
|
26 |
25 |
$2K |
| 86481 |
|
13 |
13 |
$2K |
| 82533 |
|
17 |
15 |
$2K |
| 82947 |
|
90 |
83 |
$2K |
| J9370 |
Vincristine sulfate, 1 mg |
96 |
55 |
$2K |
| 85014 |
|
58 |
57 |
$2K |
| 98960 |
|
268 |
260 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
27,376 |
24,790 |
$1K |
| 84702 |
|
13 |
12 |
$1K |
| 86922 |
|
14 |
12 |
$1K |
| 86592 |
|
27 |
25 |
$1K |
| 86900 |
|
25 |
24 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
14 |
14 |
$1K |
| 86885 |
|
12 |
12 |
$1K |
| 85018 |
|
58 |
57 |
$961.12 |
| J0136 |
Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg |
213 |
200 |
$933.96 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
718 |
663 |
$922.18 |
| 97803 |
|
1,223 |
1,166 |
$888.87 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
158 |
146 |
$844.40 |
| 84157 |
|
21 |
15 |
$828.60 |
| 92504 |
|
22 |
13 |
$812.16 |
| 0071A |
|
42 |
42 |
$759.97 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
253 |
234 |
$753.91 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
280 |
271 |
$740.52 |
| 99243 |
|
45 |
44 |
$648.59 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
226 |
214 |
$599.78 |
| 0072A |
|
18 |
18 |
$542.69 |
| 86308 |
|
42 |
42 |
$523.27 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
101 |
89 |
$502.67 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
4,260 |
3,850 |
$444.05 |
| 73080 |
|
21 |
18 |
$438.41 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
82 |
60 |
$411.78 |
| 97802 |
|
930 |
825 |
$376.73 |
| 80320 |
|
13 |
12 |
$375.45 |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
52 |
38 |
$313.80 |
| J9260 |
Injection, methotrexate sodium, 50 mg |
45 |
26 |
$308.17 |
| 86901 |
|
12 |
12 |
$285.92 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
53 |
36 |
$280.63 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
51 |
51 |
$189.90 |
| 36592 |
|
345 |
276 |
$153.75 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
59 |
58 |
$79.47 |
| 80143 |
|
13 |
12 |
$71.91 |
| 96127 |
|
2,379 |
2,319 |
$55.17 |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
71 |
67 |
$48.55 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
160 |
79 |
$9.60 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
51 |
41 |
$0.00 |
| 91307 |
|
76 |
69 |
$0.00 |
| 36416 |
|
44 |
38 |
$0.00 |
| 99024 |
|
41 |
37 |
$0.00 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
21 |
12 |
$0.00 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
12 |
12 |
$0.00 |
| A9576 |
Injection, gadoteridol, (prohance multipack), per ml |
26 |
26 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
51 |
51 |
$0.00 |